Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present)
- DOI
- 10.1517/13543776.2014.983899
- Published
- 2014-12
- Container
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa Healthcare
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1517/13543776.2014.983899,
title = {Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present)},
author = {Sylvain Celanire and Iyassu Sebhat and Juergen Wichmann and Stanislas Mayer and Stephan Schann and Silvia Gatti},
year = {2014},
journal = {Expert Opinion on Therapeutic Patents},
doi = {10.1517/13543776.2014.983899},
url = {https://doi.org/10.1517/13543776.2014.983899}
}RIS
TY - JOUR TI - Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present) AU - Sylvain Celanire AU - Iyassu Sebhat AU - Juergen Wichmann AU - Stanislas Mayer AU - Stephan Schann AU - Silvia Gatti PY - 2014 JO - Expert Opinion on Therapeutic Patents DO - 10.1517/13543776.2014.983899 UR - https://doi.org/10.1517/13543776.2014.983899 ER -
APA
Celanire, S., Sebhat, I., Wichmann, J., Mayer, S., Schann, S., & Gatti, S. (2014). Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present). Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.2014.983899
Source records
- crossref · retrieved 2026-09-27T15:18:38.935Z